Geron Corporation
GERNNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $824.96M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.04$2.01
- Volume (live)
- -
- Avg. volume (3M)
- 8.97M
Geron (GERN) Stock Price & Financial Analysis
Geron Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.17 - $1.24 |
|---|---|
| 52-Week High | $2.01 |
| 52-Week Low | $1.04 |
| Open | $1.24 |
| Volume (last close) | 3.95M |
| Average Volume (3M) | 8.97M |
| Revenue (TTM) | 204.56M |
|---|---|
| Net Income (TTM) | -67.61M |
| Free Cash Flow (TTM) | -114.79M |
| EPS (TTM) | −$0.10 |
| Profit Margin | -33.05% |
| Operating Margin | -17.25% |
| Return on Equity (ROE) | -30.93% |
| Debt to Equity | 0.55 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 824.96M |
|---|---|
| Shares Outstanding | 670.70M |
| Price to Sales (P/S) | 4.03 |
| Price to Book (P/B) | 3.77 |
| EV/EBITDA | -21.86 |
| 50-Day MA | $1.40 |
|---|---|
| 200-Day MA | $1.44 |
| 1-Year Change | +2.50% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Geron at a Glance
As of the Oct 16, 2026 close, Geron (GERN) has a market capitalization of $824.96M. The stock trades at 4.0× sales. Over the trailing twelve months it lost $67.61M on revenue of $204.56M and burned $114.79M of free cash flow. Revenue grew 24.4% year over year.
As of its latest reported balance sheet, it holds $62.64M in cash and securities against $121.14M of debt, a net debt position of $58.50M.
Geron does not currently pay a dividend.
The share price is up 2.5% over the past year. At $1.17 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $1.04 to $2.01, below its 200-day moving average of $1.44.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $4.33, 270.1% above the Oct 16, 2026 close.
Frequently Asked Questions About Geron
What is the current stock price for GERN?
As of the Oct 16, 2026 close, GERN stock trades at $1.17. The 52-week range is $1.04–$2.01, with a day range of $1.17–$1.24.
What is the P/E ratio for GERN?
The P/E ratio (Price-to-Earnings) for GERN is shown in the Key Statistics section. This valuation metric helps compare Geron Corporation to industry peers.
Does GERN pay dividends?
Geron does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for GERN?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for GERN is Buy. The average 12-month price target is $4.33, a 270.1% upside from the Oct 16, 2026 close of $1.17.
What is the market cap of GERN?
As of the Oct 16, 2026 close, Geron's market capitalization is $784.7M, classifying it as a small-cap company. Geron operates in the Healthcare sector within the Biotechnology industry.